understanding cholesterol effects of adalimumab by new techniques was another goal of gelfand and mehta's study..: "evidence for decreased calcitonin gene-related peptide (cgrp) receptors and compromised responsiveness to cgrp of fetoplacental vessels in preeclamptic pregnancies.".